Type 2 Diabetes Mellitus Completed Phase 1 Trials for Albiglutide (DB09043)

Also known as: Diabetes Mellitus, Non-insulin Dependant / Non Insulin Dependent Diabetes Mellitus / Diabetes-Mellitus, Non-Insulin Dependent / Diabetes Mellitus, Non Insulin Dependent / Diabetes Mellitus, Non-Insulin Dependent / Non-insulin-dependent Diabetes / Non Insulin Dependent Diabetes / T2DM / Noninsulin Dependent Diabetes Mellitus, Type II / Diabetes Type Two / Type Two Diabetes Mellitus / NIDDM / Non-Insulin-Dependent Diabetes Mellitus / Diabetes Mellitus Non-insulin-dependent / Type 2 Diabetes / Type 2 Diabetes Mellitus (T2DM) / Type 2 Diabetes (T2D) / Diabetes Mellitus. Type 2 / Diabetes Mellitus Type 2 / Diabetes Mellitus Type-2 / Type-2 Diabetes Mellitus / Diabetes Mellitus 2 Type / Diabetes Mellitus Type 2 (T2DM) / Diabetes Mellitus, Type 2 (T2DM) / T2DM (Type 2 Diabetes Mellitus) / Type 2 Diabetes Mellitus (T2D) / Diabetes Mellitus, Type 2 / Type-2 Diabetes / Diabetes Type 2 / Type 2 Diabetes (T2DM) / Type II Diabetes / Diabetes, Type II / Type-II Diabetes Mellitus / Type II Diabetes Mellitus / Diabetes Mellitus, Type II / Diabetes Type II / Type II; Diabetes / Diabetes Mellitus Type II / Diabetes mellitus: [adult onset] or [noninsulin dependent] / Diabetes mellitus type 2 (disorder) / Diabetes mellitus: [adult onset, with no mention of complication] or [maturity onset] or [non-insulin dependent] / Diabetes mellitus non insulin-dep / Maturity onset diabetes / Diabetes mellitus maturity onset

IndicationStatusPhase
DBCOND0029752 (Type 2 Diabetes Mellitus)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00537719Scintigraphy Study to Assess Gastric Emptying in Healthy Subjects Given GSK716155 or Placebo.Treatment
NCT00530309Clinical Assessment of GSK716155 for Type 2 Diabetes MellitusTreatment